SCHOTT Pharma AG & Co. KGaA | WebDisclosure

Basculer en Français

8296	Companies
114899	Keywords
55318	Articles
62453	Press releases

Headlines Articles Press releases SCHOTT Pharma AG & Co. KGaA

Home
Companies
SCHOTT Pharma AG & Co. KGaA

BRIEF

published on 02/29/2024 at 07:00, 8 months 21 days ago

SCHOTT Pharma has a good start to fiscal year 2024 with sustained growth

Innovation Revenue Growth SCHOTT Pharma Quarterly Results High Added Value Solutions
BRIEF

published on 02/29/2024 at 07:00, 8 months 21 days ago

SCHOTT Pharma connaît un bon début d'année fiscale 2024 avec une croissance soutenue

Innovation SCHOTT Pharma Croissance Du Chiffre D'affaires Résultats Trimestriels Solutions À Haute Valeur Ajoutée
PRESS RELEASE

published on 01/26/2024 at 07:00, 9 months 26 days ago

SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
SCHOTT Pharma AG & Co. KGaA delivers on 2023 targets with 9% revenue growth to EUR 899m and maintains high EBITDA margin of 26.6%. Strategic shift towards high-value solutions accelerates with strong profitability.

Revenue Growth EBITDA Margin SCHOTT Pharma Annual Report Forecast
PRESS RELEASE

published on 10/06/2023 at 18:10, 1 year 1 month ago

SCHOTT Pharma IPO: Early termination of stabilization period and full exercise of the Greenshoe Option
PRESS RELEASE

published on 09/27/2023 at 21:49, 1 year 1 month ago

SCHOTT Pharma IPO: Final offer price set at EUR 27.00 per share
PRESS RELEASE

published on 09/27/2023 at 21:39, 1 year 1 month ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Final offer price for shares in SCHOTT Pharma set at EUR 27.00 per share
PRESS RELEASE

published on 09/18/2023 at 07:26, 1 year 2 months ago

SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma shares to be offered within price range of EUR 24.50 to EUR 28.50 per share
PRESS RELEASE

published on 09/06/2023 at 07:21, 1 year 2 months ago

SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma plans Initial Public Offering
PRESS RELEASE

published on 06/22/2023 at 07:33, 1 year 4 months ago

SCHOTT Pharma AG & Co. KGaA: Upholding momentum: SCHOTT Pharma sustains strong growth in the first half of FY 2023
PRESS RELEASE

published on 01/26/2023 at 09:37, 1 year 9 months ago

SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma with strong financial performance in fiscal year 2022

Accesswire

Published on 11/21/2024 at 13:00, 18 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 18 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 18 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 18 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 43 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 3 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 12 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 18 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 48 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 20 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 11 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 58 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE